logo
Select company
Select metric
49.79%Cash to Assets Ratio
VS
Market
91
Sector
73
Industry
83
History
25
$ 73.43Close
$ 48.3 - $ 76.87 52-Week Range
Ticker Information

Ticker

IRMD

Company Name

IRADIMED CORP

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

IRADIMED CORP - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IRMD - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 106.45M$ 53M49.79%
3/31/2025$ 101.73M$ 50.33M49.48%
12/31/2024$ 98.33M$ 52.23M53.12%
9/30/2024$ 94.25M$ 51.72M54.88%
6/30/2024$ 89.95M$ 48.54M53.96%
3/31/2024$ 88.01M$ 45.13M51.27%
12/31/2023$ 92.16M$ 49.76M54%
9/30/2023$ 87.41M$ 46.75M53.48%
6/30/2023$ 81.43M$ 45.82M56.27%
3/31/2023$ 75.62M$ 42.78M56.57%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • IRADIMED CORP's latest trailing twelve months (TTM) Cash to Assets stands at 67.52%.
  • Over the past 5 years, IRADIMED CORP's average Cash to Assets has been 61.98%.
  • The median Cash to Assets for IRADIMED CORP during this period was 62.04%
  • IRADIMED CORP reached its highest Cash to Assets over the past 5 years at 74.81%.
  • The lowest Cash to Assets recorded by IRADIMED CORP in the same timeframe 49.48%

IRADIMED CORP's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
CBLL : CERIBELL INC 19.33%DCTH : DELCATH SYSTEMS INC 29.45%SNDX : SYNDAX PHARMACEUTICALS INC 18.26%NRIX : NURIX THERAPEUTICS INC 15.2%BFLY : BUTTERFLY NETWORK INC 47.29%NPCE : NEUROPACE INC 21.66%BLFS : BIOLIFE SOLUTIONS INC 8.24%SGHT : SIGHT SCIENCES INC 83.22%SMLR : SEMLER SCIENTIFIC INC 2.61%URGN : UROGEN PHARMA LTD 45.03%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for IRADIMED CORP is calculated as follows: CashnEq [ $ 47.55M ] / Assets [ $ 70.43M ]
(=) Cash to Assets [ 67.52% ]

IRMD - Cash to Assets Ratio, Last 5 years

49.48%

Minimum

Mar 31, 2025

74.81%

Maximum

Dec 31, 2021

61.98%

Average

62.04%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.84% with a standard deviation of 9.62%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.95K
min0%
max40.92%
average9.84%
median6.44%
std9.62%